Dr Fathi S Al-Jehani: Haematology

Home
Dr Fathi S Al-Jehani

Fee assured
Verified this account

Overview

COVID-19

This healthcare professional let us know that they are currently:

Accepting new patients
Available for:
- Face-to-face consultations
- Phone consultations
- Video consultations

Last updated: 23 May 2020

About me

I have started my career in haematology at Hammersmith Hospital and completed MSc degree with publications on CML gene expression. I have joined the south west London rotation as specialist registrar in haematology and gained high quality training on different haematology disorders. I have been a consultant in haematology for the last 12 years and working at Croydon University Hospital since 2014. I am the lead of haemato-oncology and the chair for the chemotherapy working group at the Croydon University Hospital. I have active role in teaching doctors in training and educational supervisor for F2 doctor and specialist registrar.

Areas of interest

General haematology with special interest in haemato-oncology including Myeloma; Lymphomas and leukaemias.

Medical secretaries

Practice Manager Osama Al-Jehani
162 Old School Place Croydon CR0 4GB
07411 449821
020 8401 3126
appointments@jehani.uk

About me

Current NHS consultant posts held

Consultant haematologist
Lead for Clinical Haematology
Croydon University Hospital
530 London Road
Thornton Heath
CR7 7YE

Research interests

1. Principle investigator for AML19 trial, PETRea trial, MCL bank trial and Myeloma fitness trial at Croydon University Hospital.
2. Co-investigator for FLAIR trial at Croydon University Hospital.
3. Previous PCR based research in CML at Hammersmith Hospital - London

(Additional) Languages spoken

Publications

1. Gaber KA, Eldukali WA, Al-Jehani FS. Prevalence of MRSA nasal carrier rate in
haematology patients of Benghazi Medical Center using PCR-based method; first study
in Libya. European Respiratory Journal, 2012, 40(Suppl. 56): 2498
2. Khalaf D, Al-Jehani F. Pseudo-differentiation syndrome in a patient with AML.
Mediterr J Hematol Infect Dis, 2011, 3(1): 061
3. Khalaf D, Toema B, Dabbour N, Al- Jehani F. Toxic Epidermal Necrolysis in
association with severe Cytomegalovirus infection. Mediterr J Hematol Infect Dis,
2011, 3(1): 004
4. Khalaf D, Toema Ba, Al-sadadi Sh, Al-jehani Fa, Sammak Mo. Salmonella Typhi
associated hemophagocytic lymphohistiocytosis in a previously healthy 23 years old
woman. WebmedCentral INFECTIOUS DISEASES 2011;2(3):WMC00175
5. Al- Jehani F, Khalaf D, Al-Sadadi S, Dabbour N. Ecthyma gangrenosum in a patient
with CML. Bloodmed, online, Images 183, May 2009
6. Dungerwalla M, Osuji N, Waldman A, Al-Jehani F, Mehta A, Taylor R, Wotherspoon
A, Cogill G and Matutes E. Isolated CNS involvement in adult T cell
lymphoma/leukaemia. British Journal of Haematology, 2005, 130(4), 511-515.
7. Al-Jehani F, Alsousou J, Gover P. Nephrotic syndrome associated with chronic
lymphocytic leukaemia. Hematology, 2004, 9 (5/6), 401-403.
8. Bareford D, Al-Jehani FS. Chronic myeloid leukaemia associated with hairy cell
leukaemia. Journal of Clinical Pathology, 2000, 53(12): 940-1
9. Al-Jehani FS, Spencer A, Goldman JM, Melo JV. Expression of LH2 gene in Chronic
Myeloid Leukemia. Blood, 1995, 86 (Suppl. 1): 2880.
10. Al-Jehani FS, Hochhaus A, Spencer A, Goldman JM, Melo JV. Expression of the LH2
gene in Chronic Myeloid Leukemia cells. Leukemia, 1996, 10: 1122-1126.
11. Beshyah SA, Schiff R & Al-Jehani FS. National crash call number is needed. Br.
Med. J 1996, 313 (Letter): 429.

About my work

My qualifications & training

My private practice

Report this page Print page

Finder

Covid-19

Note: